123 related articles for article (PubMed ID: 2779949)
1. Development of drug resistance in cultured clonogenic leukemic blast cells during the clinical course of myeloblastic leukemia.
Asano Y; Okamura S; Shibuya T; Morioka E; Hirota Y; Niho Y
Oncology; 1989; 46(5):339-42. PubMed ID: 2779949
[TBL] [Abstract][Full Text] [Related]
2. Drug sensitivity test for acute myeloblastic leukemia by an efficient leukemic blast colony assay using 5637-conditioned medium as a stimulator.
Asano Y; Okamura S; Shibuya T; Morioka E; Harada M; Akazawa K; Niho Y
J Med; 1990; 21(6):289-99. PubMed ID: 2093096
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
[TBL] [Abstract][Full Text] [Related]
4. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
[TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
[TBL] [Abstract][Full Text] [Related]
8. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
Nagata K; Tohda S; Suzuki T; Nara N
Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
[TBL] [Abstract][Full Text] [Related]
11. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.
Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247
[TBL] [Abstract][Full Text] [Related]
13. Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.
Campos L; Guyotat D; Jaffar C; Solary E; Archimbaud E; Treille D
Eur J Haematol; 1992 May; 48(5):254-8. PubMed ID: 1353726
[TBL] [Abstract][Full Text] [Related]
14. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
[TBL] [Abstract][Full Text] [Related]
15. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J
Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209
[TBL] [Abstract][Full Text] [Related]
16. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
[TBL] [Abstract][Full Text] [Related]
17. Effect of pharmacologically relevant concentrations of mitoxantrone on the in vitro growth of leukemic blast progenitors.
Grant S; Arlin Z; Gewirtz D; Feldman E
Leukemia; 1991 Apr; 5(4):336-9. PubMed ID: 2027301
[TBL] [Abstract][Full Text] [Related]
18. Production of growth potentiating factor(s) for autologous blast cells by acute myeloblastic leukemia cells.
Murohashi I; Nagata K; Suzuki T; Yamashita Y; Maruyama Y; Nara N
Cancer Res; 1988 Nov; 48(22):6424-8. PubMed ID: 3263187
[TBL] [Abstract][Full Text] [Related]
19. Terminal differentiation to mature neutrophils and eosinophils in suspension culture of the blast progenitors in acute myeloblastic leukemia.
Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Morio T; Bessho M; Shibuya A; Adachi Y
Hematol Pathol; 1990; 4(3):125-34. PubMed ID: 1701767
[TBL] [Abstract][Full Text] [Related]
20. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
Grant S; Pettit GR; Howe C; McCrady C
Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
